Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxin

Journal of Infectious Diseases

Volumn 194, Issue 7, 2006, Pages 1003-1007

  Hirsh, Mark I ^a   Cohen, Victoria ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; CD3 ANTIGEN; CHLOROQUINE; LETHAL TOXIN; UNCLASSIFIED DRUG;

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CROSS LINKING; CULTURE MEDIUM; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOCYTE FUNCTION; LYSOSOME; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, BACTERIAL; ANTIMALARIALS; BACTERIAL TOXINS; CHLOROQUINE; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749029677     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507311     Document Type: Article

References (15)

1. Collier RJ, Young JA. Anthrax toxin. Annu Rev Cell Dev Biol 2003; 19:45-70.
2. Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M, Montecucco C. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun 1998; 248:706-11.
3. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287:2236-52.
4. Agrawal A, Pulendran B. Anthrax lethal toxin: a weapon of multisystem destruction. Cell Mol Life Sci 2004;61:2859-65.
5. Fang H, Cordoba-Rodriguez R, Lankford CSR, Frucht DM. Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cells. J Immunol 2005; 174:4966-71.
6. Paccani SR, Tonello F, Ghittoni R, et al. Anthrax lethal toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med 2005; 201:325-31.
7. Comer JE, Chopra AK, Peterson JW, Koenig R. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun 2005; 73:8275-81.
8. Friedlander AM. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem 1986; 261:7123-6.
9. Hirsh M, Dyugovskaya L, Kaplan V, Krausz MM. Response of lung γδT cells to experimental sepsis in mice. Immunology 2004; 112:153-60.
10. Komiyama T, Swanson JA, Fuller RS. Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine. Antimicrob Agents Chemother 2005; 49:3875-82.
11. Gordon VM, Leppla SH, Hewlett EL. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun 1988; 56:1066-9.
12. O'Neill PM, Bray PG, Hawley SR, Ward SA, Park BK. 4-Amino-quinolines- past, present and future: a chemical perspective. Pharmacol Ther 1998;77:29-58.
13. Artenstein AW, Opal SM, Cristofaro P, et al. Chloroquine enhances survival in B. anthracis intoxication. J Infect Dis 2004; 190:1655-60.
14. Tournier J-N, Quesnel-Hellmann A, Mathieu J, et al. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 2005; 174:4934-41.
15. Park JM, Greten FR, Li ZW, Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 2002; 297:2048-51.